Tweenvest Stocks

Cyfuse Biomedical K.K. (TSE: 4892)

Health Care · Life Sciences Tools & Services · JP

¥565.00

+0.89% today · -12.0% 1Y

Cyfuse Biomedical K.K. (TSE: 4892) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $35.41M and employs 23 people.

Over the last twelve months the share price has lost 12.0%, trading between 487.00 and 764.00.

Tweenvest scores Cyfuse Biomedical K.K. across four factors: quality 39/100, value 59/100, growth 0/100. Its strongest factor is value.

4892 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$35.41M
Revenue (TTM)
$1.88M
P/E
EPS
-82.10
Dividend yield
Beta (5Y)
1.43
52-week high
¥764.00
52-week low
¥487.00
Avg volume (3M)
Shares outstanding
9.96M
Employees
23
Next earnings

About Cyfuse Biomedical K.K.

Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.

ISIN
JP3311800001
Founded
2010
Listed since
Dec 1, 2022
Exchange
The Tokyo Stock Exchange
Currency
JPY
CompanyMarket capPriceDay
Thermo Fisher Scientific Inc.NYSE: TMO$232.47B$628.00-0.12%
Danaher CorporationNYSE: DHR$151.22B$215.11-1.71%
WuXi AppTec Co., Ltd.SHSE: 603259$69.06BCN¥155.84-4.31%
Samsung Biologics Co.,Ltd.KOSE: A207940$51.75B1,551,000.00+0.19%
Lonza Group AGSWX: LONN$51.21BCHF593.40+0.95%
Agilent Technologies, Inc.NYSE: A$43.33B$153.43-3.50%
IQVIA Holdings Inc.NYSE: IQV$42.84B$260.24+0.16%
Waters CorporationNYSE: WAT$40.36B$410.75+0.01%

Browse every Life Sciences Tools & Services company →

Figures last refreshed Aug 18, 2026.